Interact to see
Advertisement
Advertisement
JVMSX vs TASMX
JVMSX vs TASMX Comparison
Open Charts JVMSX vs TASMX
JVMSX vs TASMX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
JVMSX vs. TASMX commentary
Jul 14, 2026
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JVMSX is a Hold and TASMX is a Buy.
FUNDAMENTALS
Fundamentals
JVMSX has more cash in the bank: 23.3B vs. TASMX (640M). TASMX pays higher dividends than JVMSX: TASMX (1.18) vs JVMSX (0.35). JVMSX was incepted earlier than TASMX: JVMSX (14 years) vs TASMX (11 years). JVMSX (1.25) is less costly to investors than TASMX (0.81). JVMSX (48.00) and TASMX (48.00) have comparable annual turnover. JVMSX (0) and TASMX (0) have matching initial minimum investment requirements. TASMX annual gain was more profitable for investors over the last year : 10.83 vs. JVMSX (5.76). JVMSX return over 5 years is better than : 11.93 vs. TASMX (-1.24).
| JVMSX | TASMX | JVMSX / TASMX | |
| Total Expense Ratio | 1.24 | 0.81 | 153% |
| Annual Report Gross Expense Ratio | 1.25 | 0.81 | 154% |
| Fund Existence | 14 years | 11 years | - |
| Gain YTD | 11.534 | 13.146 | 88% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 23.3B | 640M | 3,641% |
| Annual Yield % from dividends | 0.35 | 1.18 | 30% |
| Returns for 1 year | 5.76 | 10.83 | 53% |
| Returns for 3 years | 16.25 | 14.44 | 113% |
| Returns for 5 years | 11.93 | -1.24 | -965% |
| Returns for 10 years | 53.94 | 27.45 | 196% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ANVIX | 30.72 | N/A | N/A |
| Virtus NFJ Large-Cap Value Fund Inst | |||
| BDHAX | 9.08 | N/A | N/A |
| BlackRock Dynamic High Income Inv A | |||
| PAGHX | 143.05 | N/A | N/A |
| Permanent Portfolio Aggressive Growth C | |||
| RSMVX | 13.52 | N/A | N/A |
| William Blair Small-Mid Cap Value R6 | |||
| JFNCX | 73.02 | -0.57 | -0.77% |
| Janus Henderson Global Life Sciences C | |||